IMPROVED OUTCOMES IN PATIENTS (PTS) WITH BCL2‐POSITIVE DIFFUSE LARGE B‐CELL LYMPHOMA (DLBCL) TREATED WITH VENETOCLAX (VEN) PLUS R‐CHOP: RESULTS FROM THE PHASE 2 CAVALLI STUDY. (12th June 2019)

• Record Type: Journal Article
• Authors: Morschhauser, F.; Flinn, I.W.; Gasiorowski, R.; Illés, Á.; Feugier, P.; Greil, R.; Johnson, N.A.; Larouche, J.; Lugtenburg, P.J.; Patti, C.; Salles, G.; Trněný, M.; de Vos, S.; Mir, F.; Kornacker, M.; Punnoose, E.A.; Samineni, D.; Szafer‐Glusman, E.; Petrich, A.; Sinha, A.; Spielewoy, N.; Humphrey, K.; Bazeos, A.; Zelenetz, A.D.
• Is Part Of: Hematological oncology. Volume 37(2019)Supplement 2
• Page Start: 135
• Page End: 137
• Publication Date: 2019-06-12
• Subjects: Hematological oncology -- Periodicals; Hematology; Medical Oncology; 616.99418005
• DOI: 10.1002/hon.95_2629
• Languages: English
• ISSNs: 0278-0232